Video.
New Alzheimer’s drug gets full approval from US regulators
Copy/paste the link below:
Copy/paste the article video embed link below:
Updated:
The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months.